65 related articles for article (PubMed ID: 2376702)
1. Dose-dependent platelet stimulation and inhibition induced by anti-PIA1 IgG.
Ryu T; Davis JM; Schwartz KA
J Lab Clin Med; 1990 Jul; 116(1):91-9. PubMed ID: 2376702
[TBL] [Abstract][Full Text] [Related]
2. Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G.
Rosse WF; Devine DV; Ware R
J Clin Invest; 1984 Feb; 73(2):489-96. PubMed ID: 6699173
[TBL] [Abstract][Full Text] [Related]
3. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia.
Christie DJ; Leja DN; Carlson DL; Swinehart CD
J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
6. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
8. Precise quantitation of PAIgG: a new radiometric microtechnique.
Schwartz KA; Gauger JA; Davis JM
Am J Hematol; 1990 Mar; 33(3):167-76. PubMed ID: 2301377
[TBL] [Abstract][Full Text] [Related]
9. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.
Loughman A; Fitzgerald JR; Brennan MP; Higgins J; Downer R; Cox D; Foster TJ
Mol Microbiol; 2005 Aug; 57(3):804-18. PubMed ID: 16045623
[TBL] [Abstract][Full Text] [Related]
10. Platelet antibody in idiopathic thrombocytopenic purpura and other thrombocytopenias. A quantitative, sensitive, and rapid assay.
Sugiura K; Steiner M; Baldini MG
J Lab Clin Med; 1980 Oct; 96(4):640-53. PubMed ID: 6968331
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
12. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
13. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
14. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
Karpatkin S; Nardi MA
J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
16. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
Fernandes JB; Naik UP; Markell MS; Kornecki E
Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
[TBL] [Abstract][Full Text] [Related]
17. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
18. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
19. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
20. Human platelet activating antibodies.
Christie DJ; Swinehart CD
Semin Thromb Hemost; 1992; 18(2):186-92. PubMed ID: 1631566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
